Photomagnetic therapy method for contact dermatitis
COUNTRY OF ORIGIN
BelarusIDENTIFIER
BO13204PUBLISHED
2025-03-21LAST UPDATE
2025-03-22DEADLINE
Linked profile in other language
Responsible
Tatiana Khrustaleva
+375 17 378 1630
biblio@fizio.bas-net.by
+375 17 378 1630
biblio@fizio.bas-net.by
Summary
The Institute of Physiology offers consumers services for the use of the photomagnetic therapy method for contact dermatitis to improve the effectiveness of complex treatment and rehabilitation of patients with contact dermatitis (ICD 10 code L 23-25) under an outsourcing agreement and is looking for partners interested in a distribution services agreement.
Description
The new physiotherapeutic method of photomagnetotherapy is based on the differentiated use of a complex-modulated low-frequency pulsed magnetic field and optical radiation on the area of the pathological focus in order to increase the effectiveness of treatment and rehabilitation of patients with contact dermatitis (CD). The course of treatment includes 10 procedures.
The method is intended for physiotherapists, dermatovenerologists, and other medical specialists providing medical care to patients with contact dermatitis. Can be used both in the Republic of Belarus and in neighboring and distant foreign countries.
Information is posted in the "Album of Promising Developments of Organizations of the National Academy of Sciences of Belarus for the Real Sector of the Economy" (2023), pp. 371-372. (in Russian)
The method is intended for physiotherapists, dermatovenerologists, and other medical specialists providing medical care to patients with contact dermatitis. Can be used both in the Republic of Belarus and in neighboring and distant foreign countries.
Information is posted in the "Album of Promising Developments of Organizations of the National Academy of Sciences of Belarus for the Real Sector of the Economy" (2023), pp. 371-372. (in Russian)
Advantages and Innovations
A differentiated method of photomagnetotherapy of CD has been developed for the first time. A distinctive feature is the use of optical radiation of the green (510–550 nm), blue (460–480 nm), yellow (580–600 nm) and red (620–680 nm) spectral regions, the flux density of the studied power up to 1.0 ± 0.3 mW/cm2; in combination with a complex-modulated low-frequency pulsed magnetic field with an induction of 25 mT.
The use of photomagnetotherapy according to the developed method allows to reliably increase the therapeutic effect, reduce the duration of treatment and improve the quality of life of patients with CD.
If the instructions are followed, the method is safe. If necessary, the intensity and duration of exposure are adjusted in accordance with the instructions for use.
The use of photomagnetotherapy according to the developed method allows to reliably increase the therapeutic effect, reduce the duration of treatment and improve the quality of life of patients with CD.
If the instructions are followed, the method is safe. If necessary, the intensity and duration of exposure are adjusted in accordance with the instructions for use.
Stage of development
Already on the market
Comments regarding stage of development
The instructions for use of the "Method of photomagnetic therapy of contact dermatitis" have been implemented in the medical practice of the State Institution "City Clinical Skin and Venereal Diseases Dispensary" of Minsk (implementation act of 05/28/2018), in the educational process of the Department of Physiotherapy and Balneology of the State Educational Institution "Belarusian Medical Academy of Postgraduate Education" (implementation act of 05/23/2018) and in the complex of treatment and preventive measures of the State Unitary Enterprise "Sanatorium Belorusochka" of Minsk District (implementation act of 05/31/2018).
Funding source
State budged
Internal
Internal
IPR status
Exclusive rights
Other
Secret know-how
Other
Secret know-how
Comments regarding IPS status
Instructions for use "Method of photomagnetic therapy of contact dermatitis" by O. V. Pankratova, I. A. Smolskaya, N. I. Schastnaya, reg. No. 030-0418 dated 04.27.2018. (in Russian)
Sector group
BioChemTech
Healthcare
Healthcare
Client information
Type
R&D institution
Year established
1953
NACE keywords
M.72.11 - Research and experimental development on biotechnology
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR)
10-20M
Already engaged in transnational cooperation
Yes
Additional comments
The Institute is a leading scientific institution coordinating physiological research in the Republic of Belarus.
The institute successfully carries out fundamental and applied research aimed at developing methods for the prevention and correction of pathological conditions of hypoxic, ischemic and inflammatory genesis, and develops new devices and methods for their therapeutic and prophylactic use. The main scientific activity of the departments is currently focused on studying the mechanisms of the formation of pathological conditions of the body (primarily hypoxic and neurodestructive) and substantiating new technologies for prevention, treatment and rehabilitation. Particular attention is paid to the development of complex methods for the treatment of malignant tumors using metabolic blockade effectors and high-intensity pulsed magnetic fields and methods for controlling the proliferation of tumor cells based on changes in the functional state of neuroreceptors in vitro and in vivo, as well as the development of a method for immunotherapy of patients suffering from pancreatic cancer. , using autologous dendritic cells primed with tumor antigens and elucidating new mechanisms of tumor formation, substantiation of prevention methods. Studies of the molecular mechanisms of proliferation, differentiation and oncogenesis are being carried out; physiological and therapeutic effect of physical factors and the development of new technologies of physiotherapy and physiotherapy equipment and experimental analysis of positive and negative aspects of the use of nanoparticles and heterocyclic compounds in biomedical technologies. The neurophysiological bases of dysregulation of the functions of internal organs during ischemia of the nervous tissue of various origins are being studied. Works on the physiology of nutrition and sports are being carried out. Preclinical studies of drugs and nanomaterials are underway. Research is being carried out on the safety of biosubstances, biotherapeutic agents, pharmacological complexes and medical products on the basis of agreements with manufacturing enterprises and research institutions. The staff of the Institute conducts research on the mechanisms of interaction between neurons and glial cells in normal and pathological conditions. The functional role of biological preparations (platelet-rich plasma, suspension of mitochondria, mesenchymal stem cells, etc.) in the activation of reparative processes in strokes and brain injuries, ischemia of the lower extremities is being studied. Methods for stable remote monitoring of vital human functions (heart, blood vessels, respiration, temperature, motor activity, brain activity) are being developed. Particular attention is paid to the study of the functional role of the extracellular matrix and stem cells in the development of neoplasms. Cell technologies are being developed for the treatment of malignant diseases. The Institute also evaluates the therapeutic and therapeutic-prophylactic properties of natural mineral waters and the effectiveness of pre- and probiotics - food, food supplements.
Close scientific cooperation is carried out with scientists from Russia, China and Uzbekistan.
The institute successfully carries out fundamental and applied research aimed at developing methods for the prevention and correction of pathological conditions of hypoxic, ischemic and inflammatory genesis, and develops new devices and methods for their therapeutic and prophylactic use. The main scientific activity of the departments is currently focused on studying the mechanisms of the formation of pathological conditions of the body (primarily hypoxic and neurodestructive) and substantiating new technologies for prevention, treatment and rehabilitation. Particular attention is paid to the development of complex methods for the treatment of malignant tumors using metabolic blockade effectors and high-intensity pulsed magnetic fields and methods for controlling the proliferation of tumor cells based on changes in the functional state of neuroreceptors in vitro and in vivo, as well as the development of a method for immunotherapy of patients suffering from pancreatic cancer. , using autologous dendritic cells primed with tumor antigens and elucidating new mechanisms of tumor formation, substantiation of prevention methods. Studies of the molecular mechanisms of proliferation, differentiation and oncogenesis are being carried out; physiological and therapeutic effect of physical factors and the development of new technologies of physiotherapy and physiotherapy equipment and experimental analysis of positive and negative aspects of the use of nanoparticles and heterocyclic compounds in biomedical technologies. The neurophysiological bases of dysregulation of the functions of internal organs during ischemia of the nervous tissue of various origins are being studied. Works on the physiology of nutrition and sports are being carried out. Preclinical studies of drugs and nanomaterials are underway. Research is being carried out on the safety of biosubstances, biotherapeutic agents, pharmacological complexes and medical products on the basis of agreements with manufacturing enterprises and research institutions. The staff of the Institute conducts research on the mechanisms of interaction between neurons and glial cells in normal and pathological conditions. The functional role of biological preparations (platelet-rich plasma, suspension of mitochondria, mesenchymal stem cells, etc.) in the activation of reparative processes in strokes and brain injuries, ischemia of the lower extremities is being studied. Methods for stable remote monitoring of vital human functions (heart, blood vessels, respiration, temperature, motor activity, brain activity) are being developed. Particular attention is paid to the study of the functional role of the extracellular matrix and stem cells in the development of neoplasms. Cell technologies are being developed for the treatment of malignant diseases. The Institute also evaluates the therapeutic and therapeutic-prophylactic properties of natural mineral waters and the effectiveness of pre- and probiotics - food, food supplements.
Close scientific cooperation is carried out with scientists from Russia, China and Uzbekistan.
Languages spoken
English
Russian
Russian
Information about partnership
Type of partnership considered
Distribution services agreement
Outsourcing agreement
Outsourcing agreement
Type and role of partner sought
Consumers interested in purchasing services for using the photomagnetic therapy method for contact dermatitis to improve the effectiveness of complex treatment and rehabilitation of patients with contact dermatitis (ICD 10 code L 23-25) under an outsourcing agreement.
Partners interested in purchasing services for using the photomagnetic therapy method for contact dermatitis to improve the effectiveness of complex treatment and rehabilitation of patients with contact dermatitis (ICD 10 code L 23-25) under a distribution services agreement.
Partners interested in purchasing services for using the photomagnetic therapy method for contact dermatitis to improve the effectiveness of complex treatment and rehabilitation of patients with contact dermatitis (ICD 10 code L 23-25) under a distribution services agreement.
Type and size of partner sought
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University
Sole proprietor
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University
Sole proprietor
Attachments
Количество уникальных просмотров в одной сессии: 71
Статистика ведется с 21.03.2025 14:42:46
Статистика ведется с 21.03.2025 14:42:46